HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

3rd Edition of

World Orthopedics Conference

September 15-17, 2025 | London, UK

Ortho 2025

LARS synthetic ligaments: A new frontier?

Speaker at World Orthopedics Conference 2025 - Massimo Piracci
Medcare Orthopedic and Spine Hospital, United Arab Emirates
Title : LARS synthetic ligaments: A new frontier?

Abstract:

Introduction: The Ligament Augmentation and Reconstruction System (LARS)  is designed to replicate the mechanical and anatomical properties of natural ligaments.The LARS synthetic ligament is made of 100% industrial strength polyester fibers. Each LARS contains a specific number and length of fibers, depending on their intended use. The active intra-articular portion of the LARS is made of longitudinal fibers, called “free fibers” without transversal fibers. The fibers are oriented according to the ligament they are made for, to mimic the anatomic fibers. This patented structure allows a high resistance to fatigue especially to flexion, torsion stresses and while observing a minimum residual elongation of the ligament. This porous and flexible structure allows colonization of the tissue. LARS in 5 points:

  • Rapid return to sporting activities.
  • Minimal invasive surgery, mainly by arthroscopy no long period of immobilization required.
  • Full range of motion after 3 weeks no muscular atrophy.
  • LARS is suitable for: The upper extremities: Rotator cuff tears, acromioclavicular, joint dislocation, distal biceps tears and others.
  • The lower extremities: Anterior and posterior cruciate ligaments reconstruction ( intra articular), posteral lateral corner, quadriceps tears, patellar tendon tears and achilles tendon repairs (extra articular) and others. The LARS synthetic ligament can be used as an augmentation device in conjunction with autograft or allograft in acute or chronic injuries. 

Objectives: This hybrid technique has revolutionized the use of synthetic ligaments in all types of reconstruction indications. The combination of biological and synthetic implants will create a homogenous fusion, thus creating a new hybrid approach. Combining biologic tissues and a synthetic implant to provide a fusion between both elements. A hybrid application will provide strength (early recovery with no elongation) and durability (extended life time).In acute (≥ 3 weeks) cases, the LARS ligament will work as an augmentation device combined with stump of the ACL. In chronic or revision cases, the LARS ligament is combined with a graft as an augmentation device intended for stress shielding.The postoperative care varies according to the technique used and the joint being repaired such as knee, shoulder, ankle. Generally, these indications apply: The LARS ligament enables you to start physiotherapy the next day after surgery so there will be no limitations, rapid full range of motion, less muscle atrophy, quicker return to sports and no brace is necessary. 

Methods: Many publications through the years have demonstrated the use of LARS ligaments to have it's advantages versus conventional techniques. In a meta analysis study Jian Sun & all reserched in PubMed, Cochrane Library, and EMBASE for published Randomized Controlled Trials (RCT) and Case Controlled Trials (CCTs) to compare the outcomes of the autografts versus synthetics after cruciate ligament reconstruction. Nine studies were identified from the literature review. Of these studies, three studies compared the results of Bone–Patellar Tendon– Bone (BPTB) and ligament augmentation and reconstruction system (LARS), while six studies compared the results of Four-Strand Hamstring Tendon Graft (4SHG) and LARS. 

Result & Discussion: The comparative study showed no difference in Lysholm score and failure risk between autografts and synthetics. The combined results of the meta-analysis indicated that there was a significantly lower rate of side-to-side in the synthetics group than in the autografts group. This systematic review comparing long-term outcomes after cruciate ligament reconstruction with either autograft or synthetics suggests no significant differences in failure risk. Autografts were inferior to synthetics with respect to restoring knee joint stability and patient-reported outcome scores, and were also associated with more postoperative complications. Conclusion: In conclusion, the combination of synthetic and biological ligaments, you benefit from the best of both worlds.

Biography:

Massimo Piracci completed his MBBS from Roma Tor Vergata, Italy in 1992 and subsequently received his MD in Orthopedic and Traumatology from the same University in 1999. He was trained in Orthopedic Surgery in Roma Saint Eugenio Hospital and in Latina Santa Maria Goretti Hospital. From 2003 was HOD in Orthopedic and Traumatology Department in Roma Clinic Annunziatella where he did more than 10.000 surgery. He was also Football Referee for FIGC for 15 years and also external orthopedic consultant for different football team. From 2014 in UAE. He uses the most advanced technologies and biological implant (PRP, Stamina cells, Ozone Therapy) and mini invasive surgery of hip head. He treats the most of orthopedic pathology for children and adults, the most of minor and major trauma, and sport injury with advanced mini invasive technique. For low back pain he uses the treatment with Ozone therapy that resolve the pain giving back a normal life to the patient. He was the HOD of Orthopedic department in Czech Rehabilitation Hospital in Al Ain and HOD of Regenerative and Sport Medicine in Adam Vital Hospital in Dubai. Consultant Orthopedic Surgeon in Saudi German Hospital in Dubai. Consultant Orthopedic surgeon in Emirates Hospital Group, he is Consultant Orthopedic surgeon, Regenerative Medicine and Sport Medicine in Medcare Orthopedic Spinal Hospital Dubai. Speaker well known in many National and International Conference and publishing.

Watsapp